封面
市場調查報告書
商品編碼
1982762

全球低內毒素明膠市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Low Endotoxin Gelatin Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計低內毒素明膠市場將從 2025 年的 2.6705 億美元成長到 2034 年的 4.6241 億美元,2026 年至 2034 年的複合年成長率為 6.29%。

由於低內毒素明膠在製藥和生物技術領域的重要性,全球低內毒素明膠市場持續成長。低內毒素明膠經過特殊加工去除細菌內毒素,適用於藥物傳遞系統、疫苗和生物醫學研究等對物質含量要求較高的醫療應用。醫療領域對高純度材料日益成長的需求,顯著推動了對這種特殊明膠的需求。

多種因素正在推動低內毒素明膠市場的擴張。製藥和生物技術產業的快速發展增加了對醫療產品所用高品質原料的需求。此外,藥物研發和再生醫學研究活動的活性化也擴大了低內毒素明膠在實驗室和臨床環境中的應用。

隨著生物醫學研究的進步,低內毒素明膠市場預計將持續成長。製藥生產的創新以及對安全有效醫療產品日益成長的需求,預計將進一步推動高純度明膠材料的應用。此外,生物技術研究的拓展預計也將為市場的長期發展提供支持。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球低內毒素明膠市場:依產品類型分類

  • 市場分析、洞察與預測
  • A型
  • B型

第5章:全球低內毒素明膠市場:依來源分類

  • 市場分析、洞察與預測
  • 源自豬
  • 源自牛
  • 其他

第6章:全球低內毒素明膠市場:依應用領域分類

  • 市場分析、洞察與預測
  • 製藥
  • 醫療設備
  • 生物技術
  • 研究與開發
  • 其他

第7章:全球低內毒素明膠市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 研究機構
  • 製藥公司
  • 其他

第8章 全球低內毒素明膠市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Gelita AG
    • Nitta Gelatin Inc
    • Rousselot BV
    • PB Gelatins/PB Leiner
    • Weishardt Group
    • Sterling Gelatin
    • Great Lakes Gelatin Company
    • Tessenderlo Group
    • Lapi Gelatine SPA
    • Qinghai Gelatin Co. Ltd
    • India Gelatine & Chemicals Ltd
    • Geltech Co. Ltd
    • Narmada Gelatines Ltd
    • Trobas Gelatine BV
    • Junca Gelatines SL
簡介目錄
Product Code: VMR11212364

The Low Endotoxin Gelatin Market size is expected to reach USD 462.41 Million in 2034 from USD 267.05 Million (2025) growing at a CAGR of 6.29% during 2026-2034.

The global low endotoxin gelatin market has grown steadily due to its importance in pharmaceutical and biotechnology applications. Low endotoxin gelatin is specially processed to remove bacterial endotoxins, making it suitable for sensitive medical uses such as drug delivery systems, vaccines, and biomedical research. The increasing focus on high-purity materials in healthcare has significantly boosted demand for this specialized gelatin.

Several factors are driving the expansion of the low endotoxin gelatin market. The rapid growth of the pharmaceutical and biotechnology industries has increased the need for high-quality raw materials used in medical products. Additionally, rising research activities in drug development and regenerative medicine have expanded the use of low endotoxin gelatin in laboratory and clinical settings.

In the future, the low endotoxin gelatin market is expected to continue growing as biomedical research advances. Innovations in pharmaceutical manufacturing and increasing demand for safe and effective medical products may drive further adoption of high-purity gelatin materials. Furthermore, expanding biotechnology research initiatives will likely support long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Type A
  • Type B

By Source

  • Porcine
  • Bovine
  • Fish
  • Others

By Application

  • Pharmaceuticals
  • Medical Devices
  • Biotechnology
  • Research and Development
  • Others

By End-User

  • Hospitals
  • Research Institutes
  • Pharmaceutical Companies
  • Others

COMPANIES PROFILED

  • Gelita AG, Nitta Gelatin Inc, Rousselot BV, PB GelatinsPB Leiner, Weishardt Group, Sterling Gelatin, Great Lakes Gelatin Company, Tessenderlo Group, Lapi Gelatine Spa, Qinghai Gelatin Co Ltd, India Gelatine Chemicals Ltd, Geltech Co Ltd, Narmada Gelatines Ltd, Trobas Gelatine BV, Junca Gelatines SL
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Type A Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Type B Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY SOURCE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Source
  • 5.2. Porcine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Bovine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Source
    • 8.2.3 By Application
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Source
    • 8.3.3 By Application
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Source
    • 8.4.3 By Application
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Source
    • 8.5.3 By Application
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Source
    • 8.6.3 By Application
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL LOW ENDOTOXIN GELATIN INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Gelita AG
    • 10.2.2 Nitta Gelatin Inc
    • 10.2.3 Rousselot BV
    • 10.2.4 PB Gelatins/PB Leiner
    • 10.2.5 Weishardt Group
    • 10.2.6 Sterling Gelatin
    • 10.2.7 Great Lakes Gelatin Company
    • 10.2.8 Tessenderlo Group
    • 10.2.9 Lapi Gelatine S.P.A
    • 10.2.10 Qinghai Gelatin Co. Ltd
    • 10.2.11 India Gelatine & Chemicals Ltd
    • 10.2.12 Geltech Co. Ltd
    • 10.2.13 Narmada Gelatines Ltd
    • 10.2.14 Trobas Gelatine BV
    • 10.2.15 Junca Gelatines SL